Investor insights
Countries invested in
Sectors invested in
Funding rounds participated in
$1.5M sweet spot round size
Most of their 84 investments are in rounds between $25M and $60M
Investor type
Basic info
Industry
Sectors
Date founded
2000
Investments made
Garuda Therapeutics raised $62M on February 7, 2023
Investors: Sectoral Asset Management, Northpond Ventures, OrbiMed Advisors and Aisling Capital
Forge Biologics raised $90M on September 12, 2022
Investors: Drive Capital and Aisling Capital
Garuda Therapeutics raised $72M on September 23, 2021
Investors: Sectoral Asset Management, Tatleaux Partners, LLC, Northpond Ventures, Ridgeback Capital Management LLC, Monashee Investment Management LLC, OrbiMed Advisors and Aisling Capital
Wugen raised $172M on July 15, 2021
Investors: RiverVest Venture Partners, Sands Capital Management, Intermediate Capital Group (ICG), LYZZ CAPITAL and Aisling Capital
Biomea Fusion raised $56M on January 6, 2021
Investors: RTW Investments, LP, Logos Global Management, LP and Aisling Capital
Reneo Pharmaceuticals raised $95M on December 9, 2020
Investors: RiverVest Venture Partners, Chiesi Ventures, Lundbeckfonden / Lundbeck Foundation, Pappas Capital, Abingworth and Aisling Capital
Elevation Oncology raised $33M on July 21, 2020
Investors: Vertex Ventures HC, Driehaus Capital Management LLC and Aisling Capital
Spruce Biosciences raised $88M on February 20, 2020
Investors: Omega Funds, RiverVest Venture Partners, Surveyor Capital, Sands Capital Management, HealthCap, Abingworth, Novo Holdings and Aisling Capital
Nuvation Bio raised $275M on October 28, 2019
Investors: Omega Funds, The Baupost Group, EDBI Pte Ltd and Aisling Capital
Ajax Health raised $15M on June 18, 2019
Investors: Polaris Partners, HealthQuest Capital and Aisling Capital